
KBC
Description
KBC, a prominent Belgian financial services group, actively engages in venture capital through its dedicated investment vehicle, KBC Focus Fund. Established in 2015, the fund was initially capitalized with €50 million, aiming to provide development capital to innovative, early-stage technology companies. This strategic initiative underscores KBC's commitment to fostering growth within the digital economy, primarily focusing on the Belgian market. The fund targets disruptive technologies across various sectors, including FinTech, InsurTech, HealthTech, Cyber Security, Artificial Intelligence, Big Data, and the Internet of Things, reflecting a forward-looking investment strategy.
In a significant expansion of its commitment, KBC increased the fund's capital to €100 million in 2021. This substantial boost allows KBC Focus Fund to make more impactful investments and support its portfolio companies through various growth stages. While the user's description broadly mentions "medium-sized companies" and "Central and Eastern Europe," KBC Focus Fund's explicit mandate is geared towards early-stage disruptive tech in Belgium. However, their investments are designed to help these startups scale into significant players, and they actively participate in follow-on funding rounds to support this growth trajectory.
KBC Focus Fund typically deploys initial cheques ranging from €0.5 million to €4 million. These investments are often made in collaboration with co-investors, enabling the fund to participate in larger funding rounds and build a diversified portfolio of high-potential ventures. Through its focused approach, KBC aims to drive innovation and contribute to the development of a robust technology ecosystem within its core market.
Investor Profile
KBC has backed more than 27 startups, with 1 new investments in the last 12 months alone. The firm has led 8 rounds, about 30% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in Belgium, United States, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Biopharma.
- Typical check size: $540K – $4.3M.
Stage Focus
- Series A (30%)
- Seed (26%)
- Series B (11%)
- Series C (7%)
- Pre Seed (7%)
- Series D (4%)
- Series E (4%)
- Series F (4%)
- Series Unknown (4%)
- Post Ipo Debt (4%)
Country Focus
- Belgium (63%)
- United States (22%)
- United Kingdom (4%)
- Switzerland (4%)
- France (4%)
- Luxembourg (4%)
Industry Focus
- Biotechnology
- Health Care
- Biopharma
- Pharmaceutical
- Fintech
- Health Diagnostics
- Software
- Information Technology
- Financial Services
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.